Gilliland Jeter Wealth Management LLC Has $536,000 Position in STERIS plc (NYSE:STE)

Gilliland Jeter Wealth Management LLC reduced its stake in shares of STERIS plc (NYSE:STE) by 8.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,608 shares of the medical equipment provider’s stock after selling 244 shares during the quarter. Gilliland Jeter Wealth Management LLC’s holdings in STERIS were worth $536,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Ashton Thomas Securities LLC acquired a new position in shares of STERIS in the 3rd quarter valued at approximately $25,000. Central Pacific Bank Trust Division grew its position in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares during the period. Quarry LP acquired a new position in shares of STERIS in the 3rd quarter valued at approximately $67,000. Asset Dedication LLC grew its position in shares of STERIS by 54.8% in the 3rd quarter. Asset Dedication LLC now owns 291 shares of the medical equipment provider’s stock valued at $71,000 after purchasing an additional 103 shares during the period. Finally, R Squared Ltd acquired a new position in shares of STERIS in the 4th quarter valued at approximately $78,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at STERIS

In related news, SVP Cary L. Majors sold 1,682 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the sale, the senior vice president now owns 11,372 shares in the company, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.14% of the stock is owned by company insiders.

STERIS Trading Up 2.1 %

Shares of STERIS stock opened at $225.44 on Friday. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The stock has a market cap of $22.25 billion, a P/E ratio of 51.47 and a beta of 0.84. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average is $212.33 and its 200-day moving average is $224.59.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.78% and a net margin of 8.02%. Equities research analysts predict that STERIS plc will post 9.11 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is presently 52.05%.

Wall Street Analysts Forecast Growth

STE has been the subject of several research analyst reports. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Friday, November 8th. JMP Securities restated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday. Finally, Stephens restated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.